Last reviewed · How we verify
NCT05972031: EMBOSS
EMBOSS A Person-centred Integrated-care for Chronic Diseases in Patients of Low Socio Economic Status
NA trial testing Person-centred integrated care intervention in Chronic Condition in 540 participants. Status unknown.
1 August 2024
Quick facts
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 540 |
| Start date | 29 January 2023 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Person-centred integrated care intervention
Conditions studied
- Chronic Condition — all drugs for Chronic Condition →
- Chronic Conditions, Multiple — all drugs for Chronic Conditions, Multiple →
Sponsor
Radboud University Medical Center
Who can join
18 and older, any sex, with Chronic Condition or Chronic Conditions, Multiple. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People of low socio economic status (SES) more often than others suffer from chronic diseases like diabetes mellitus, chronic obstructive pulmonary disease (COPD), or coronary diseases. Compared to others People of low SES more often have to deal with multiple diseases (multimorbidity) and experience worse health outcomes. The health literacy of people of low SES is often low. Current chronic disease management programs focus on reducing the burden of a single disease by prescribing medication, protocoled monitoring routines, or lifestyle advice. However, the effectiveness of these interventions is low in people with low SES, as the interventions insufficiently take into account the specific problems and needs of this (multimorbid) population. A person-centered and integrated-care approach, that puts the patient at the center of care instead of the disease and in which care is tailored to the individual patient with chronic disease(s), seems to be more appropriate, but only when low SES people are closely involved in the development, testing, and evaluation of such an approach. Also, certain preconditions should be met, such as training of specific knowledge and skills of the healthcare professionals involved. In the EMBOSS project, the investigators will develop, test, evaluate, and implement a person-centered integrated-care approach for and in close collaboration with people with low SES who have one or more chronic diseases. Thus, the EMBOSS study will have the potential to reducing health disparities in this group, to broadening the action perspectives of general practitioners and practice nurses for an increasing diverse patient population and to a better fit of lifestyle interventions in people of low SES.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Co-creating a person-centred approach in primary care for patients with low socioeconomic status and chronic conditions: <i>a participatory learning & action study</i>.
van Bommel HE, van den Muijsenbergh METC, Bergsma B, Burgers JS, et al · · 2025 · cited 1× · PMID 40977445 · DOI 10.1017/s1463423625100431 -
Optimizing Study Design for Evaluating Complex Interventions: An Example of a Feasibility Study in Person-Centered and Integrated Chronic Disease Care in Dutch General Practice.
Raaijmakers LHA, Schermer TR, van Bommel HE, Vercoulen JH, et al · · 2025 · PMID 41209624 · DOI 10.5334/ijic.8998
Verify or expand the search:
- PubMed search for NCT05972031
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Person-centred integrated care intervention
Trials testing the same drug.
- NCT05495230 — OPTIMA FORMA Phase 3 · NA · completed
Other recruiting trials for Chronic Condition
Currently open trials in the same condition.
- NCT06070766 — RIVER At Home Ketamine Protocols · recruiting
Other Radboud University Medical Center trials
Trials by the same sponsor.
- NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
- NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
- NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
- NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
- NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05972031 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
- Last refreshed: 6 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05972031.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing